Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › RNase L activators and antisense oligonucleotides effective to treat RSV infections

RNase L activators and antisense oligonucleotides effective to treat RSV infections

US Patent 5998602 · Granted Dec 7, 1999

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Preparation method for losartan2025
Waterproof motor2025
Traditional Chinese medicine composition and use thereof2025
Audio signal enhancement method and apparatus, computer device, storage medium a2025
Zavarzinia compransoris capable of degrading organophosphorus flame retardant an2025
Speech enhancement method and apparatus, device, and storage medium2025
Cerium dioxide-supported low-dose PtCu ultrafine alloy catalyst, preparation met2025
Speech enhancement method and apparatus, device, and storage medium2025
Method and apparatus for operating blockchain system, device and storage medium2025
Speech signal processing method and apparatus, electronic device, and storage me2025
Application interface display method and electronic device2025
Voice processing method and apparatus, electronic device, and computer-readable 2025